Drug profile · INN
atorvastatin calcium
LYPQOZET
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
atorvastatin calcium (LYPQOZET) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN atorvastatin calcium
Brand LYPQOZET
Route ORAL
Formulation SUSPENSION
Originator Teva Pharma GmbH
Related patents
Search patents →Frequently asked questions
What is atorvastatin calcium?
atorvastatin calcium (LYPQOZET) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for atorvastatin calcium?
LYPQOZET is a marketed brand name for atorvastatin calcium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of atorvastatin calcium?
atorvastatin calcium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.